www
GlaxoSmithKline (NYSE: GSK) is recently down $3.75 to $42.13.
GSK reported a declining Q4 pre-tax profit and warned 2008 earnings will be negatively affected by decreasing sales of diabetes drug Avandia, competition from generics and a weak dollar.
GSK overall option implied volatility of 26 is near its 26-week average according to Track Data, suggesting non-directional risk.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
| # | Blogger | Posts | Cmts |
|---|---|---|---|
| 1 | Joseph Lazzaro | 50 | 0 |
| 2 | Connie Madon | 47 | 0 |
| 3 | Steven Mallas | 44 | 0 |
| 4 | Steven Halpern | 41 | 0 |
| 5 | Mark Fightmaster | 40 | 0 |
| 6 | Zac Bissonnette | 39 | 0 |
| 7 | Tom Taulli | 36 | 0 |
| 8 | Sheldon Liber | 24 | 0 |
| 9 | Tom Johansmeyer | 23 | 0 |
| 10 | Brian White | 23 | 0 |
| 11 | Trey Thoelcke | 22 | 0 |
| 12 | Jim Cramer | 20 | 0 |
| 13 | Melly Alazraki | 20 | 0 |
| 14 | Paul Foster | 20 | 0 |
| 15 | Jamie Dlugosch | 19 | 0 |
| 16 | Jon Ogg | 18 | 0 |
| 17 | Eric Buscemi | 18 | 0 |
| 18 | Elizabeth Harrow | 18 | 2 |
| 19 | Brent Archer | 17 | 0 |
| 20 | Michael Fowlkes | 11 | 0 |
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
Other Weblogs Inc. Network blogs you might be interested in:
Entrepreneur's Journal: Key steps for telesales success
The week in preview: Focus returns to earnings: Alcoa, Chevron, Family Dollar
Comfort Zone Investing: Survival of the fittest -- letting some banks fail
